Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Climate change and its implications for kidney health.

Current opinion in urology·2024
Same author

Thiazides do not affect mortality but may reduce CV events vs. nondiuretic antihypertensive drugs at up to 5 y.

Annals of internal medicine·2023
Same author

Cellular Cytosolic Energy Replenishment Increases Vascularized Composite Tissue Tolerance to Extended Cold Ischemia Time.

Military medicine·2022
Same author

Glycine improves peritoneal vasoreactivity to dialysis solutions in the elderly.

Qatar medical journal·2020
Same author

Propranolol attenuates cognitive, learning, and memory deficits in a murine model of traumatic brain injury.

The journal of trauma and acute care surgery·2019
Same author

Outcomes After Massive Transfusion in Trauma Patients: Variability Among Trauma Centers.

The Journal of surgical research·2018

Related Experiment Videos

Vasoactive components of dialysis solution.

El Rasheid Zakaria1, Anuj A Patel, Na Li

  • 1Department of Physiology and Biophysics, University of Louisville, Louisville, KY 40292, USA. erzaka01@louisville.edu

Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|May 14, 2008
PubMed
Summary
This summary is machine-generated.

Peritoneal dialysis (PD) solutions cause vasodilation, primarily due to hyperosmolarity and glucose uptake, with glucose degradation products also contributing. Lactate in PD solutions is vasoactive only at low pH.

Related Experiment Videos

Area of Science:

  • Nephrology
  • Physiology
  • Biochemistry

Background:

  • Conventional peritoneal dialysis (PD) solutions induce vasodilation, affecting solute transport.
  • The specific vasoactive components within PD solutions remain debated.
  • This study aimed to identify the vasoactive agents in PD solutions.

Purpose of the Study:

  • To determine the vasoactive components of conventional and novel peritoneal dialysis (PD) solutions.
  • To investigate the impact of osmolarity, buffer systems, and glucose degradation products (GDPs) on PD-induced vasodilation.
  • To elucidate the role of lactate and pH in PD solution vasoactivity.

Main Methods:

  • Intravital video microscopy was used to visualize microvascular changes in rat ileum.
  • Measurements of microvascular diameter and blood flow were performed.
  • Solutions tested included clinical PD solutions and custom-formulated solutions to isolate vasoactive components.

Main Results:

  • All tested PD solutions caused rapid vasodilation, influenced by arteriolar size, osmotic solute, and buffer anion system.
  • Hyperosmolar glucose solutions induced greater vasodilation than hyperosmolar mannitol solutions.
  • Lactate-containing solutions were vasoactive only at low pH, similar to icodextrin solutions.

Conclusions:

  • Hyperosmolarity is the primary driver of vasodilation induced by PD solutions.
  • Hyperosmolarity and glucose uptake contribute significantly to vasodilation, with GDPs playing a lesser role.
  • Lactate's vasoactivity is pH-dependent, and overall vasodilation is influenced by osmotic solute, GDPs, and pH.